NEW YORK (GenomeWeb News) – An epigenetic modification that involves the methylation of adenosine in RNA is more common in mammalian cells than previously appreciated, according to a study online today in Cell.

A Cornell University team used immunoblotting, along with an antibody-based enrichment and sequencing method dubbed MeRIP-Seq, to look at N6-methyladenosine profiles in messenger RNA and non-coding RNAs from several mammalian tissues and cell lines.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.